Aptinyx, Magenta lead IPO flurry ahead of summer lull by Phil Taylor Thursday, June 21, 2018 No fewer than five biotech IPOs debuted Thursday, raising more than $460 million and with more in the offing if underwriters take up further options.
Atlas gene therapy startup Avrobio files for $86M IPO by Nick Paul Taylor Tuesday, May 29, 2018 The IPO would give Avrobio the means to trial gene therapies designed to supplant enzyme replacement therapies from Sanofi, Shire and Pfizer.
Avrobio pulls in $60M to push Fabry, Gaucher candidates through the clinic by Amirah Al Idrus Thursday, February 1, 2018 With the financing, Avrobio plans to push its pipeline through the clinic "as aggressively as possible."
